Humberto C. Antunes, worldwide CEO of Galderma has been honored with a "Lifetime in Dermatology Achievement Award" from the Journal of Drugs in Dermatology (JDD). The award was presented at the Orlando Dermatology Aesthetic & Clinical Conference (ODAC) held January 17-20, 2014, in Florida.
In 2013, the JDD requested nominations from the entire dermatology community, including the JDD editorial board, authors, and reviewers, for companies regarded among their peers as the very best thought leaders in a particular dermatology specialty.
Galderma was elected to receive the prestigious JDD Leaders of Distinction Award and chosen as the Leader of Distinction for the "Lifetime in Dermatology Achievement Award."
"Galderma is one of the world's leading pharmaceutical companies in dermatology, and also one of the most generous, much of which would not be possible without Humberto Antunes' leadership, dedication and philanthropy to the industry," said Perry Robins, MD, ODAC Conference Chair Emeritus and Professor Emeritus of Dermatology at New York University School of Medicine. "I have had the pleasure of knowing Humberto for many, many years and in that vein, it gives me great pleasure to honor him with the Journal of Drugs in Dermatology 'Lifetime in Dermatology Achievement Award,' and know that he will continue to positively shape the future of dermatology.”
Antunes is a Brazilian-born, Swiss-based dermatology veteran with 30 years of experience. He has been with Galderma for 17 years.
